Your session is about to expire
← Back to Search
Cetuximab + Bevacizumab for Brain Tumor
Study Summary
This trial tests if monthly infusions of cetuximab and bevacizumab can safely and effectively treat young people with brain tumors.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Logistics
Participation is compensated
You will be compensated for participating in this trial.
Who is running the clinical trial?
Media Library
- I have a confirmed diagnosis of a specific type of brain tumor.I do not have any major health or mental conditions that would make treatment risky for me.I haven't had chemotherapy in the last three weeks.I am on a stable or decreasing dose of steroids for my brain tumor.I am not pregnant or breastfeeding.I haven't taken growth factor treatments in the last week.I had a craniotomy more than 2 weeks ago, or it's been 4 weeks since my last Avastin therapy if I had any major surgery planned.I can care for myself but may need occasional help.My blood tests show enough neutrophils and platelets.
- Group 1: SIACI of cetuximab and bevacizumab
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Under what conditions are individuals eligible to participate in this trial?
"Eligibility for this study requires that participants possess a diagnosis of oligodendroglioma and are between 1 year old and 21 years old. Currently, the team is looking to recruit around 20 individuals."
Are there any current opportunities to partake in this research?
"According to the records on clinicaltrials.gov, this study is not currently recruiting patients; it was initially posted in October of 2023 and revised most recently in July 14th of that same year. Despite this particular trial's lack of recruitment activity at present time, there are 759 other trials actively searching for participants right now."
Is the age-range for this research limited to those over 35 years old?
"This research initiative necessitates that participants be between 1 and 21 years of age, as indicated in the selection criteria."
Share this study with friends
Copy Link
Messenger